Artem Baranovskii retweeted
Artem from our lab presenting, for the first time, #gASOline , our tool for antisense oligonucleotide design leveraging RNA foundation models at #ncrna2024 in Basel.@FrogToadson @CompHealthMuc . Very grateful for all the biological insights on that!
Artem Baranovskii retweeted
📢📢 we received 970 applications for this year's computational #genomics focusing on #machineLearning applications. Thank you for the overwhelming interest, we will get back to the applicants in 7-10 days. @BIMSB_MDC @MDC_Berlin
Artem Baranovskii retweeted
Correct link: genomebiology.biomedcentral.…
🚨🚨Our new publication on #SingleCell #genomics + #Cancer + #MachineLearning !! How to define cancer cells in the single-cell context? 🧵 1/n 🧵 @GenomeBiology @MDC_Berlin @BIMSB_MDC @arcas_ai genomebiology.biomedcentral.…
Artem Baranovskii retweeted
We are often asked, "what is the benefit of using multi-omics for #cancer patient stratification over panel #sequencing". answer: up to 5-fold improvement for #drug response #prediction. Limitations apply, details 👉 biorxiv.org/content/10.1101/… #MachineLearning #oncology #Genomics
Artem Baranovskii retweeted
Toxic gain-of-function mutations in glycyl-tRNA synthase, underlying neurodegeneration in Charcot–Marie–Tooth disease, function by sequestering tRNAᴳˡʸ and causing ribosomes to pause at glycine codons.
academic.oup.com/nar/advance…
